Thierry Langer
professor at the University of Vienna
Accessing biological actions of Ganoderma secondary metabolites by in silico profilingEnhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?Hit finding: towards 'smarter' approachesIntegrated in silico tools for exploiting the natural products' bioactivity.Molecule-pharmacophore superpositioning and pattern matching in computational drug designPharmacophores for medicinal chemists: a personal view.Predicting drug metabolism induction in silicoRational drug design paradigms: the odyssey for designing better drugs.Strategies for efficient lead structure discovery from natural products.Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.Virtual screening for the discovery of bioactive natural productsVirtual screening: an effective tool for lead structure discovery?Why drugs fail--a study on side effects in new chemical entities.Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1.
author
Thierry Langer
professor at the University of Vienna
affiliation
gender
sameAs
U-8621-2017
type
comment
professor at the University of Vienna
@en
wetenschapper
@nl
研究者
@ja
研究者
@zh
연구원
@ko
label
Thierry Langer
@ast
Thierry Langer
@de
Thierry Langer
@en
Thierry Langer
@es
Thierry Langer
@nl
Thierry Langer
@sl